Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ SARS-CoV-2 Nucleocapsid Recombinant Rabbit Monoclonal Antibody (HL453)
Rabbit Recombinant Monoclonal Antibody
Supplier: Invitrogen™ MA536272
Description
This antibody detects both SARS-CoV nucleocapsid and SARS-CoV-2 nucleocapsid proteins. Our internal testing indicates no cross-reactivity with MERS-CoV nucleocapsid protein.
SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus. The SARS-CoV-2 N protein is an abundant RNA-binding protein critical for viral genome packaging, yet the molecular details that involve this process are poorly understood. N protein contains three dynamic disordered regions that house putative transiently-helical binding motifs. The two folded domains interact minimally such that full-length N protein is a flexible and multivalent RNA-binding protein. SARS-CoV-2 causes illnesses ranging from the common cold to severe diseases.
Specifications
SARS-CoV-2 Nucleocapsid | |
Recombinant Monoclonal | |
1 mg/mL | |
PBS with no preservative | |
P0DTC9 | |
N | |
Full length SARS-CoV-2 (COVID-19) nucleocapsid Recombinant protein. | |
100 μL | |
Primary | |
Virus | |
Antibody | |
IgG |
ELISA, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
HL453 | |
Unconjugated | |
N | |
COVID19 Nucleocapsid; COVID-19 nucleocapsid; COVID19 Spike nucleocapsid; SARS-CoV-2 N | |
Rabbit | |
Protein A | |
RUO | |
43740575 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction